David Andrew Hoffman - 03 Jan 2023 Form 4 Insider Report for First Wave BioPharma, Inc. (ENTO)

Role
Director
Signature
/s/ David Hoffman
Issuer symbol
ENTO
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 07:56:53 UTC
Previous filing
04 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FWBI Common Stock Award $0 +84,745 +1405% $0.000000 90,778 03 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 3, 2023, the Reporting Person was granted 84,745 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning March 31, 2023.
F2 Includes unvested RSUs.